documents

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

7 rows where docket_id = "FDA-2024-E-3865" sorted by posted_date descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: title, subtype, posted_date, posted_month, comment_start_date, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)

posted_year 2

document_type 2

agency_id 1

id agency_id docket_id title document_type subtype posted_date ▲ posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2024-E-3865-0007 FDA None FDA-2024-E-3865 Determination of Regulatory Review Period for Purposes of Patent Extension; OJEMDA Notice Determinations 2025-12-29T05:00:00Z 2025 12 2025-12-29T05:00:00Z 2026-02-28T04:59:59Z 2025-12-29T19:57:00Z 2025-23867 0 0 09000064b910a301
FDA-2024-E-3865-0006 FDA None FDA-2024-E-3865 Letter to U.S. Patent and Trademark Office Other Letter(s) 2025-08-19T04:00:00Z 2025 8 2025-08-19T04:00:00Z   2025-08-19T22:20:43Z   0 0 09000064b8f0859c
FDA-2024-E-3865-0005 FDA None FDA-2024-E-3865 Letter from U.S. Patent and Trademark Office to FDA CDER Other Letter(s) 2025-07-15T04:00:00Z 2025 7 2025-07-15T04:00:00Z   2025-07-15T19:46:05Z   0 0 09000064b8e6f0f1
FDA-2024-E-3865-0004 FDA None FDA-2024-E-3865 Letter from FDA CDER to U. S. Patent and Trademark Office Other Letter(s) 2025-06-30T04:00:00Z 2025 6 2025-06-30T04:00:00Z   2025-06-30T20:41:57Z   0 0 09000064b8e4299d
FDA-2024-E-3865-0003 FDA None FDA-2024-E-3865 Patent Extension Application from Day One Biopharmaceuticals, Inc. (on behalf of Viracta Therapeutics, Inc.) for NDA 218033 Other Application 2024-08-19T04:00:00Z 2024 8 2024-08-19T04:00:00Z   2024-08-19T12:31:40Z   0 0 090000648664423a
FDA-2024-E-3865-0001 FDA None FDA-2024-E-3865 Letter from U.S. Patent and Trademark Office to FDA CDER Other Letter(s) 2024-08-19T04:00:00Z 2024 8 2024-08-19T04:00:00Z   2024-08-19T12:31:20Z   0 0 0900006486644236
FDA-2024-E-3865-0002 FDA None FDA-2024-E-3865 Patent Extension Application from Day One Biopharmaceuticals, Inc. (on behalf of Viracta Therapeutics, Inc.) for NDA 217700 Other Application 2024-08-19T04:00:00Z 2024 8 2024-08-19T04:00:00Z   2024-08-19T12:31:30Z   0 0 0900006486644238

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options: 

CREATE TABLE documents (
    id TEXT PRIMARY KEY,
    agency_id TEXT,
    docket_id TEXT REFERENCES dockets(id),
    title TEXT,
    document_type TEXT,
    subtype TEXT,
    posted_date TEXT,
    posted_year INTEGER,
    posted_month INTEGER,
    comment_start_date TEXT,
    comment_end_date TEXT,
    last_modified TEXT,
    fr_doc_num TEXT,
    open_for_comment INTEGER,
    withdrawn INTEGER,
    object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;